These patients showed a trend towards more vessel inflammation in the muscle biopsy (10% vs 1%, P = 0.07), less myalgia (33% vs 54%, P = 0.07), lower CK median levels (459 vs 823, P = 0.06) and lower cellularity in the biopsy characterized by less CD68 + (68% vs 85%, P = 0.07) and CD45 + cells (64% vs 79%, P = 0.10) when compared with the anti-FHL1 – counterpart ( Supplementary Table S3 , available at Rheumatology online).
The change (delta) in post- versus pre-VR future self-similarity between abstainers and those relapsing showed a trend-level difference (1.6 ± 2.0 and − 0.7 ± 0.6, respectively), t (18) = 1.93, p = 0.070, but did not reach significance.
BDHI scores had a positive correlation with f P within the BD group (R = 0.63, P = .01), and BDI scores showed a trend toward positive correlation with f P (R = 0.42, P = .07).
However, it is worth mentioning that our data showed a trend towards signification between these two groups ( p = 0.070).
Exploratory analysis revealed that mutations in the homologous repair pathway showed a trend for higher ORR (100% vs 0%, p=0.07).
The mean Manders M2 coefficient was calculated for each subject, and Student’s t -test showed a trend ( T = −2.18, P = 0.07) towards increased overlap of GSK3β signal with nuclear staining in Control versus Alzheimer’s disease ( Fig. 4C ), providing likely validation of the mass spectrometry results.
IL6 increased ( p < 0.05) in females (12.1-fold change) and showed a trend ( p = 0.07) for an increase in males (19.6-fold change; Figure 6C ).
The RT of the right stimulation condition (422.2 ± 16.9 ms) was significantly smaller than that of the bilateral stimulation condition ( adj P < 0.05) and showed a trend toward being smaller than that of the no-stimulation condition ( adj P = 0.07).
Although only 7% of patients (43/659) received the cisplatin plus 5-fluorouracil regimen because of the covid-19 pandemic and late enrolment of western populations, this regimen also showed a trend for survival benefit (hazard ratio for overall survival 0.31, 95% confidence interval 0.08 to 1.20, P=0.07).
Interestingly, the overall time point comparisons using the Friedman test showed a trend towards variability of gut microbiome composition related to the distinct dietary interventions (p = 0.07 for unweighted UniFrac and p = 0.19 for weighted UniFrac distances), thereby pointing to an overall dynamic microbiome community throughout the study. 3.3.
Patients with allergic side effects during the entire course of VIT showed a trend towards higher rApi m 5 values when compared to the group without allergic side effects: median [Q25–Q75] 0.41 [0.01–1.12] vs. 0.04 [0–0.50] p = 0.07 ( Table 7 ).
Sex concordance between patient and provider showed a trend toward impacting the rates of electrophysiology referrals (HR, 1.18 [95% CI, 0.99–1.42]; P =0.07) but not of ICD implantations (HR, 1.12 [95% CI, 0.91–1.37]; P =0.27).
Replacement fibrosis expressed by LGE was present in 37 (74%) patients and only showed a trend towards a differentiation between the groups with and without nsVT ( p = 0.07).
In a correlation analysis, CD4 + TNFa + significantly correlated with the mean increase in antibody titers after the vaccine boost (correlation coefficient, 0.58; P = .029), and correlation of CD4 + INFγ + with mean antibody increase showed a trend toward statistical significance (correlation coefficient, 0.49; P = .07).
Based on Faith Phylogenetic diversity that assessed using the Tukey Honest Significant Difference method, the probable pigs had a higher phylogenetic diversity level compared to healthy pigs ( p = 0.045) and showed a trend towards greater diversity than the confirmed group ( p = 0.07) (Fig. 1 b).
PS supplementation showed a trend towards improving perceived stress levels during teeing-off (mean: pre-test 5.8 ± 2.0, post-test 4.0 ± 2.0, p = 0.07), whereas stress levels remained unchanged in the placebo group (mean: pre-test: 5.1 ± 2.0, post-test: 5.1 ± 3.1).
The 5 × 4 mixed-model ANCOVA still showed a trend to statistically significant time*group interaction ( p = 0.07) and time*sex interaction ( p = 0.08), with no effect of nVAS ( p = 0.835), the amount of LTRs ( p = 0.61), or group*sex interaction ( p = 0.77) for changes in PPT.
Similarly, energy drink intake showed a trend toward higher consumption in late sleepers (p=0.07).
Patients with serial isolates showed a trend towards earlier clinical infection (5 vs 8 days, P = 0.07).
However, patients who received CT, showed a trend toward improved survival with GTR (HR: 0.70, 95% CI: 0.48–1.03, p = 0.070).
Compared to the control group, intervention group scores for the short-form 12 health survey physical component ( P =.04) and FSQ basic ADL ( P =.02) improved significantly, and BPI pain interference showed a trend of improvement ( P =.07).
ASYMAD and CN did not show significant differences in the amount of tau, yet the ASYMAD group showed a trend toward greater tau in the MFG as compared with CN ( P = 0.07).
Caffeine citrate showed a >10-fold increase in TGFβ2 expression from 0 to 48 h which was not seen with the other isoforms, while dexamethasone showed a trend towards increased TGFβ3 expression by 48 h (p = 0.07).
Patients on biologic therapy reported dyspnea less frequently (biologic 1/25, 4.0%; nonbiologic 23/110, 20.9%, P = .04) but showed a trend toward increased HS flares (biologic 12/25, 48.0%; nonbiologic 32/110, 29.4%, P = .07) and longer time to COVID-19 resolution (biologic: median (interquartile range) 21 (14-31) days; nonbiologic: 14 (9-25) days, P = .07).
Analysis of sp3 VSL showed a trend of the triple interaction due to extender, temperature, and time ( p = 0.07), revealing consistent effects with that described for VSL in the global sperm population. 3.2.2.